Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bronx, New York 10461


Purpose:

The gut hormone glucagon like peptide-1 (GLP-1) has been shown to have important effects on maintaining the function and health of the insulin producing beta cells. This hormone is known to increase the production rate of new insulin as well as increase the release of insulin into the blood. We will measure the rate of new insulin production in subjects with Type 2 diabetes compared to non diabetic subjects. We hypothesize that subjects with Type 2 diabetes make less insulin in response to GLP-1 compared to non diabetic subjects.


Criteria:

Inclusion Criteria: Type 2 Diabetes Non diabetic, weight, sex, age matched Exclusion Criteria: TZD, metformin, Exenatide, sitagliptin CHF, CAD CRF Anemia


NCT ID:

NCT00609154


Primary Contact:

Principal Investigator
Daniel Stein, MD
Albert Einstein College of Medicine of Yeshiva University

Cynthia Rivera, RN
Phone: 718-430-2446
Email: carivera@aecom.yu.edu


Backup Contact:

N/A


Location Contact:

Bronx, New York 10461
United States

Cynthia Rivera, RN
Phone: 718-430-2446
Email: carivera@aecom.yu.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 22, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.